“…However, no ideal therapeutics or vaccine against S. suis infections is available thus far, although some researches showed homologous protection (Baums et al, 2009;Feng et al, 2014;Fittipaldi et al, 2012). To date, a multitude of virulence factors have been reported, such as MRP (Li et al, 2017b;Wisselink et al, 2001), SLY (Du et al, 2013;Jacobs et al, 1996), EF (Wisselink et al, 2001), enolase (Esgleas et al, 2009;Feng et al, 2009;Zhang et al, 2009), HtpsC (Li et al, 2015a), and HP0272 (Chen et al, 2010;Pian et al, 2012), but the pathogenesis of S. suis infections remains poorly understood (Fittipaldi et al, 2012).…”